ID29970A - Metode untuk mengobati penyakit neovaskuler okuler - Google Patents
Metode untuk mengobati penyakit neovaskuler okulerInfo
- Publication number
- ID29970A ID29970A IDW00200101090A ID20011090A ID29970A ID 29970 A ID29970 A ID 29970A ID W00200101090 A IDW00200101090 A ID W00200101090A ID 20011090 A ID20011090 A ID 20011090A ID 29970 A ID29970 A ID 29970A
- Authority
- ID
- Indonesia
- Prior art keywords
- treating
- oulner
- methods
- neovascular disease
- neovascular
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000005590 Choroidal Neovascularization Diseases 0.000 abstract 1
- 206010060823 Choroidal neovascularisation Diseases 0.000 abstract 1
- 206010029113 Neovascularisation Diseases 0.000 abstract 1
- 208000007135 Retinal Neovascularization Diseases 0.000 abstract 1
- 230000002207 retinal effect Effects 0.000 abstract 1
- HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical class C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19867798A | 1998-11-23 | 1998-11-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID29970A true ID29970A (id) | 2001-10-25 |
Family
ID=22734344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW00200101090A ID29970A (id) | 1998-11-23 | 1999-11-22 | Metode untuk mengobati penyakit neovaskuler okuler |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1131073B1 (de) |
| JP (2) | JP2002530342A (de) |
| KR (1) | KR100698449B1 (de) |
| CN (1) | CN1172673C (de) |
| AT (1) | ATE252387T1 (de) |
| AU (1) | AU761092B2 (de) |
| BR (1) | BR9915569A (de) |
| CA (1) | CA2348890C (de) |
| DE (1) | DE69912304T2 (de) |
| DK (1) | DK1131073T3 (de) |
| ES (1) | ES2211197T3 (de) |
| ID (1) | ID29970A (de) |
| IL (2) | IL142757A0 (de) |
| NO (1) | NO328085B1 (de) |
| NZ (1) | NZ511559A (de) |
| PT (1) | PT1131073E (de) |
| WO (1) | WO2000030651A1 (de) |
| ZA (1) | ZA200103925B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0122318D0 (en) * | 2001-09-14 | 2001-11-07 | Novartis Ag | Organic compounds |
| US20030119812A1 (en) * | 2001-11-08 | 2003-06-26 | Brazzell Romulus Kimbro | Method for decreasing capillary permeability in the retina |
| EP1531793A1 (de) * | 2002-07-23 | 2005-05-25 | Novartis AG | Augensalbenzusammensetzung mit einem arzneimittel, einer salbengrundlage und einem l slichmachenden/dispergierenden mittel |
| MX2007001155A (es) * | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1. |
| CN101580515B (zh) * | 2008-05-16 | 2011-06-08 | 上海医药工业研究院 | 一种星形孢菌素提取纯化的方法 |
| US8614221B2 (en) | 2009-03-11 | 2013-12-24 | Merck Sharp & Dohme Corp. | Inhibitors of Akt activity |
| WO2010114780A1 (en) | 2009-04-01 | 2010-10-07 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| CN102924479A (zh) * | 2011-08-09 | 2013-02-13 | 山东鲁北药业有限公司 | 一种星孢菌素类衍生物的半合成方法 |
| WO2013039854A1 (en) | 2011-09-15 | 2013-03-21 | Merck Sharp & Dohme Corp. | Compositions and methods for treating cancer |
| RS56680B1 (sr) | 2012-11-28 | 2018-03-30 | Merck Sharp & Dohme | Kompozicije i postupci za lečenje kancera |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5093330A (en) * | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
| IL86632A0 (en) * | 1987-06-15 | 1988-11-30 | Ciba Geigy Ag | Derivatives substituted at methyl-amino nitrogen |
| JPH08502033A (ja) * | 1992-07-08 | 1996-03-05 | セルトリックス ファーマシューティカルズ，インコーポレイテッド | ＴＧＦ−βを用いる眼疾患の治療方法 |
| US6410322B1 (en) * | 1993-07-27 | 2002-06-25 | Hybridon Inc | Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| AU2066797A (en) * | 1996-03-21 | 1997-10-10 | Sugen, Inc. | Assays for kdr/flk-1 receptor tyrosine kinase inhibitors |
| UA54427C2 (uk) * | 1996-05-01 | 2003-03-17 | Елі Ліллі Енд Компані | Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту |
| CA2321560C (en) * | 1998-03-13 | 2007-05-22 | Johns Hopkins University School Of Medicine | The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation |
-
1999
- 1999-11-22 DE DE69912304T patent/DE69912304T2/de not_active Expired - Lifetime
- 1999-11-22 WO PCT/EP1999/008987 patent/WO2000030651A1/en not_active Ceased
- 1999-11-22 EP EP99957321A patent/EP1131073B1/de not_active Expired - Lifetime
- 1999-11-22 ID IDW00200101090A patent/ID29970A/id unknown
- 1999-11-22 CA CA002348890A patent/CA2348890C/en not_active Expired - Fee Related
- 1999-11-22 NZ NZ511559A patent/NZ511559A/xx not_active IP Right Cessation
- 1999-11-22 AT AT99957321T patent/ATE252387T1/de active
- 1999-11-22 JP JP2000583534A patent/JP2002530342A/ja not_active Ceased
- 1999-11-22 PT PT99957321T patent/PT1131073E/pt unknown
- 1999-11-22 ES ES99957321T patent/ES2211197T3/es not_active Expired - Lifetime
- 1999-11-22 BR BR9915569-9A patent/BR9915569A/pt not_active Application Discontinuation
- 1999-11-22 KR KR1020017006415A patent/KR100698449B1/ko not_active Expired - Fee Related
- 1999-11-22 IL IL14275799A patent/IL142757A0/xx active IP Right Grant
- 1999-11-22 AU AU15066/00A patent/AU761092B2/en not_active Ceased
- 1999-11-22 CN CNB99813600XA patent/CN1172673C/zh not_active Expired - Fee Related
- 1999-11-22 DK DK99957321T patent/DK1131073T3/da active
-
2001
- 2001-04-23 IL IL142757A patent/IL142757A/en not_active IP Right Cessation
- 2001-05-15 ZA ZA200103925A patent/ZA200103925B/en unknown
- 2001-05-21 NO NO20012490A patent/NO328085B1/no not_active IP Right Cessation
-
2011
- 2011-02-07 JP JP2011023933A patent/JP2011088938A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1328462A (zh) | 2001-12-26 |
| NO20012490D0 (no) | 2001-05-21 |
| NO20012490L (no) | 2001-06-25 |
| NZ511559A (en) | 2004-01-30 |
| KR20010078398A (ko) | 2001-08-20 |
| EP1131073B1 (de) | 2003-10-22 |
| NO328085B1 (no) | 2009-11-30 |
| CA2348890C (en) | 2009-05-12 |
| CN1172673C (zh) | 2004-10-27 |
| ZA200103925B (en) | 2002-07-25 |
| DK1131073T3 (da) | 2004-02-02 |
| KR100698449B1 (ko) | 2007-03-23 |
| JP2002530342A (ja) | 2002-09-17 |
| JP2011088938A (ja) | 2011-05-06 |
| IL142757A (en) | 2007-07-04 |
| BR9915569A (pt) | 2001-08-14 |
| DE69912304T2 (de) | 2004-07-22 |
| EP1131073A1 (de) | 2001-09-12 |
| PT1131073E (pt) | 2004-03-31 |
| AU1506600A (en) | 2000-06-13 |
| ES2211197T3 (es) | 2004-07-01 |
| HK1040182A1 (en) | 2002-05-31 |
| DE69912304D1 (de) | 2003-11-27 |
| WO2000030651A1 (en) | 2000-06-02 |
| ATE252387T1 (de) | 2003-11-15 |
| AU761092B2 (en) | 2003-05-29 |
| CA2348890A1 (en) | 2000-06-02 |
| IL142757A0 (en) | 2002-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60138137D1 (de) | Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen | |
| LU91928I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
| DK0841949T3 (da) | Anvendelse af saccharid-konjugater | |
| EP1173484A4 (de) | Behandlung von fibrose durch antagonismus zwischen il-13 und il-13-rezeptorketten | |
| DE69834658D1 (de) | Verwendung von aminothiolverbindungen zur behandlung von nerven- und nieren-erkrankungen und der arzneimitteltoxizität | |
| PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
| ECSP045098A (es) | Procedimientos para tratar enfermedades neovasculares oculares | |
| ATE323482T1 (de) | Verwendung von p38 mapk inhibitoren in der behandlung von augenkrankheiten | |
| AP2002002596A0 (en) | Piperazine and piperidine derivatives. | |
| ATE144898T1 (de) | Behandlung neurodegenerativer krankheiten | |
| AP2004003124A0 (en) | Thiazole and oxazole derivatives which modulate PPAR activity | |
| BR0210241A (pt) | Piranoindazóis e seu uso no tratamento de glaucoma | |
| DE69940951D1 (de) | Nd wachstumshemmende mittel | |
| NO990912D0 (no) | Terapeutiske kombinasjoner av PAR-antagonister og RXR-antagonister og deres anvendelse | |
| MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
| BR0109499A (pt) | Tratamento melhorado de neovascularização | |
| ID29970A (id) | Metode untuk mengobati penyakit neovaskuler okuler | |
| DE69613386D1 (de) | Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen | |
| EP1110554A4 (de) | Medizinische zusammensetzungen zur behandlung von augenerkrankungen | |
| DE60130872D1 (de) | Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer | |
| WO2000009098A3 (en) | Method for treating ocular neovascular diseases | |
| EE200100026A (et) | Oksasolidinoonid silmahaiguste raviks | |
| DE60138385D1 (de) | Heilmittel zur behandlung von erkrankungen des sehnervs | |
| SE9403160D0 (sv) | Method and means for prevention and treatment of secondary cataract | |
| DE69916013D1 (de) | Vorderkammerimplantat zur behandlung des phaken auges |